Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine after craniotomy for ICU sedation
IRCT20170716035104N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Dexmedetomidine with Placebo (normal saline) (2 arms). Primary endpoints: Richmond Agitation-Sedation Scale, Complications due to dexmedetomidine intake and 1 more. Started Dec 2018; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20170716035104N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170716035104N2.